Acasia Technology 

$1
0
-$9-90% Thursday 21:00

Statistics

Day High
1
Day Low
1
52W High
10
52W Low
0.54
Volume
2,500
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Dec 15
$1.25
Sep 15
$1.25
Jun 15
$1.25
Mar 15
$1.25
Dec 14
$1.25
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-41,000Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow ACAT. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap140.15B
Pfizer is a global pharmaceutical company that competes with NPLS in the development and marketing of medications and vaccines for a wide range of diseases.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson operates in the pharmaceutical, medical devices, and consumer health sectors, directly competing with NPLS across multiple health industry segments.
Merck
MRK
Mkt Cap214.76B
Merck is known for its wide range of pharmaceutical products, including vaccines, biologic therapies, and animal health products, making it a direct competitor to NPLS.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie competes with NPLS in the biopharmaceutical field, focusing on treatments for conditions such as rheumatoid arthritis, psoriasis, and Crohn's disease.
AMGEN
AMGN
Mkt Cap160.66B
Amgen is a biotechnology company that competes with NPLS in developing innovative human therapeutics, with a focus on oncology, cardiovascular disease, and neuroscience.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol Myers Squibb is a global biopharmaceutical company that competes with NPLS in the discovery, development, and delivery of medicines for cancer, cardiovascular diseases, and immune disorders.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences is a biopharmaceutical company that competes with NPLS in the development and marketing of antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza.
Novartis
NVS
Mkt Cap237.61B
Novartis is a global healthcare company that competes with NPLS by providing solutions in pharmaceuticals and generics that address a wide range of diseases and chronic conditions.
Roche
RHHBY
Mkt Cap258.9B
Roche Holding AG is a leader in research-focused healthcare with strengths in pharmaceuticals and diagnostics, competing with NPLS in areas such as oncology, immunology, and infectious diseases.
Thermo Fisher Scientific
TMO
Mkt Cap214.25B
Thermo Fisher Scientific competes with NPLS by providing scientific instrumentation, reagents and consumables, and software and services to healthcare, life science, and other laboratories.

About

GJ Culture Group US, Inc. provides educational and other related services based on classical Chinese studies and culture. The company offers international study tours, which include the youth study tour series, adult study tour series, and themed study tour series of culture and art. It also provides lectures on classical studies; meditation courses; education and training services; and cultural events and art exhibitions. In addition, the company offers consulting and planning services to its contracted Chinese partners, including telephone or online consultation regarding market and research analysis of classical Chinese culture study in the United States for the business activities or international tour proposed by its Chinese partners, as well as online oral trainings to the staff of its Chinese business partners. It serves the Chinese-Americans, American youths, scholars, art collectors, and professional and corporate executives interested in learning about Chinese culture. The company was formerly known as Guojiang Cultural Industry US, Inc. and changed its name to GJ Culture Group US, Inc. in February 2019. GJ Culture Group US, Inc. was incorporated in 2018 and is based in Danville, California.
Show more...
CEO
ISIN
US36253J3041

Listings

0 Comments

Share your thoughts

FAQ

What is Acasia Technology stock price today?
The current price of ACAT is $1 USD — it has decreased by -90% in the past 24 hours. Watch Acasia Technology stock price performance more closely on the chart.
What is Acasia Technology stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Acasia Technology stocks are traded under the ticker ACAT.
Is Acasia Technology stock price growing?
ACAT stock has fallen by -90% compared to the previous week, the month change is a +0% rise, over the last year Acasia Technology has showed a +85.53% increase.
What is Acasia Technology revenue for the last year?
Acasia Technology revenue for the last year amounts to 0 USD.
What is Acasia Technology net income for the last year?
ACAT net income for the last year is -41,000 USD.
Does Acasia Technology pay dividends?
Yes, ACAT dividends are paid quarterly. The last dividend per share was 1.25 USD. As of today, Dividend Yield (FWD)% is 0%.
In which sector is Acasia Technology located?
Acasia Technology operates in the Other sector.
When did Acasia Technology complete a stock split?
The last stock split for Acasia Technology was on October 28, 2025 with a ratio of 1:10.